AAV5-miHTT gene therapy for Huntington disease: lowering both huntingtins. | Expert Opin Biol Ther;20(10): 1121-1124, 2020 10. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

AAV5-miHTT gene therapy for Huntington disease: lowering both huntingtins.

Evers, Melvin M; Konstantinova, Pavlina.

Affiliation

Evers MM; Research, uniQure biopharma B.V , Amsterdam, The Netherlands.
Konstantinova P; Research, uniQure biopharma B.V , Amsterdam, The Netherlands.

Expert Opin Biol Ther ; 20(10): 1121-1124, 2020 10.

Article in En | MEDLINE | ID: mdl-32658606

Key words

AAV5; ASO; HTT; Huntington disease; adeno-associated virus; antisense oligonucleotide; huntingtin lowering; microRNA

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Expert Opin Biol Ther Journal subject: BIOLOGIA / TERAPEUTICA Year: 2020 Document type: Article Affiliation country: Países Bajos Country of publication: Reino Unido

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Expert Opin Biol Ther Journal subject: BIOLOGIA / TERAPEUTICA Year: 2020 Document type: Article Affiliation country: Países Bajos Country of publication: Reino Unido